KBC Group NV Trims Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

KBC Group NV lessened its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 93.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,131 shares of the medical instruments supplier's stock after selling 16,172 shares during the quarter. KBC Group NV's holdings in ICU Medical were worth $157,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of ICUI. GAMMA Investing LLC lifted its position in shares of ICU Medical by 27.2% during the first quarter. GAMMA Investing LLC now owns 716 shares of the medical instruments supplier's stock worth $99,000 after purchasing an additional 153 shares in the last quarter. SG Americas Securities LLC acquired a new stake in shares of ICU Medical during the first quarter worth about $859,000. Vanguard Group Inc. lifted its position in shares of ICU Medical by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier's stock worth $416,176,000 after purchasing an additional 17,805 shares in the last quarter. Norges Bank acquired a new stake in shares of ICU Medical during the fourth quarter worth about $40,151,000. Finally, Proficio Capital Partners LLC acquired a new stake in ICU Medical in the fourth quarter valued at approximately $5,779,000. Hedge funds and other institutional investors own 96.10% of the company's stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on ICUI shares. Raymond James Financial reduced their target price on shares of ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating on the stock in a report on Friday, May 9th. Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. KeyCorp reduced their target price on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Finally, Wall Street Zen raised shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Sunday, May 18th. One investment analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, ICU Medical presently has an average rating of "Buy" and a consensus price target of $192.67.

ICU Medical Stock Performance

Shares of ICUI traded up $1.53 during mid-day trading on Thursday, reaching $137.26. 196,277 shares of the company's stock were exchanged, compared to its average volume of 259,606. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.59 and a quick ratio of 1.52. The stock has a market capitalization of $3.38 billion, a PE ratio of -35.84 and a beta of 0.87. The business's fifty day simple moving average is $133.89 and its 200-day simple moving average is $145.29. ICU Medical, Inc. has a 52-week low of $117.92 and a 52-week high of $196.26.

ICU Medical (NASDAQ:ICUI - Get Free Report) last announced its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.23 by $0.49. The business had revenue of $599.49 million for the quarter, compared to analyst estimates of $574.15 million. ICU Medical had a negative net margin of 3.87% and a positive return on equity of 6.75%. The company's revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period last year, the firm posted $0.96 earnings per share. On average, equities research analysts expect that ICU Medical, Inc. will post 4.11 earnings per share for the current year.

Insider Activity

In other ICU Medical news, Director Elisha W. Finney sold 600 shares of the stock in a transaction that occurred on Monday, May 19th. The shares were sold at an average price of $138.92, for a total value of $83,352.00. Following the completion of the sale, the director owned 3,252 shares of the company's stock, valued at $451,767.84. This trade represents a 15.58% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Ben Sousa sold 2,000 shares of the stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $137.36, for a total transaction of $274,720.00. Following the completion of the sale, the insider directly owned 479 shares of the company's stock, valued at $65,795.44. This trade represents a 80.68% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 36,097 shares of company stock valued at $4,860,156 in the last 90 days. Company insiders own 1.50% of the company's stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.